Parasitology and Mycology Rapid Tests and Point of Care (POC) Pipeline Research Report 2023 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Parasitology and Mycology Rapid Tests and POC Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update” report has been added to ResearchAndMarkets.com’s offering.

Parasitology & Mycology Pipeline Report provides comprehensive information about the Parasitology & Mycology pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

This report provides extensive coverage of Parasitology & Mycology under development, offering comprehensive insights into pipeline products, major players, developmental activities, clinical trial data, and recent developments in the segment/industry.

The report reviews the details of major pipeline products, including product descriptions, licensing and collaboration details, and other developmental activities related to Parasitology & Mycology. It also lists all the pipeline projects involving major players engaged in the development of Parasitology & Mycology. Coverage of pipeline products is based on various stages of development, ranging from Early Development to Approved/Issued stages, allowing readers to understand the progress of these products in the pipeline.

Key clinical trial data related to ongoing trials specific to pipeline products in the Parasitology & Mycology segment is provided, offering valuable insights into the clinical development of these products.

Reasons to Buy

• Formulate significant competitor information, analysis, and insights to improve R&D strategies
• Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
• Identify and understand important and diverse types of Parasitology & Mycology under development
• Develop market-entry and market expansion strategies
• Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
• In-depth analysis of the product’s current stage of development, territory and estimated launch date

Key Topics Covered:

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 Parasitology & Mycology Overview

3 Products under Development

3.1 Parasitology & Mycology – Pipeline Products by Stage of Development

3.2 Parasitology & Mycology – Pipeline Products by Territory

3.3 Parasitology & Mycology – Pipeline Products by Regulatory Path

3.4 Parasitology & Mycology – Pipeline Products by Estimated Approval Date

4 Parasitology & Mycology – Pipeline Products under Development by Companies

4.1 Parasitology & Mycology Companies – Pipeline Products by Stage of Development

4.2 Parasitology & Mycology – Pipeline Products by Stage of Development

5 Parasitology & Mycology Companies and Product Overview

6 Parasitology & Mycology- Recent Developments

7 Appendix

A selection of companies mentioned in this report includes

• Abacus Diagnostica Ltd
• Access Bio Inc
• Acobiom
• Adaltis Srl
• All India Institute of Medical Sciences
• Antigen Discovery Inc
• Applied BioCode Inc
• Aptus Biotech SL
• Attogene Corp
• Auburn University
• Axxin
• Beckman Coulter Inc
• BioSynesis Inc
• Biotechnology Assets SA
• Biotype Innovation GmbH
• Cascade Biosystems Inc
• Cepheid Inc
• Cerebro Biosystems
• Ceres Nanosciences Inc
• Ellume Ltd
• EUROIMMUN US LLC
• FK-Biotecnologia SA
• Foundation for Innovative New Diagnostics
• Fungea AB
• G Medical Health and Wellness
• Genetag Technology, Inc
• Gennova Biopharmaceuticals Ltd
• Genome Diagnostics Pvt Ltd
• George Mason University
• Great Basin Scientific Inc.
• HealthTell Inc
• Immunetics Inc
• InBios International Inc
• Institute for Development Research
• Johns Hopkins University
• L2 Diagnostics LLC
• London School of Hygiene & Tropical Medicine
• Luminex Corp
• Mahidol Oxford Tropical Medicine Research Unit
• Masaryk University
• Massachusetts Institute of Technology
• McGill University
• Meridian Bioscience Inc
• Microbiologics Inc
• MiraVista Diagnostics LLC
• MND Diagnostic LTD
• MycoDART Inc
• Mylab Discovery Solutions Pvt Ltd
• Nagasaki University
• Nanosphere Inc (Inactive)
• NextGen Invitro Diagnostics Pvt Ltd
• Novacyt SA
• Ohio State University
• OpGen Inc
• OPKO Health Inc
• Oregon Health & Science University
• Ortho Clinical Diagnostics Holdings Plc
• Pai Life Sciences Inc
• Paramedical Srl
• Peruvian Cayetano Heredia University
• Phagolum Ltd.
• PixCell Medical Technologies Ltd
• Praxis Pharmaceutical SAU
• Proplex Technologies Llc
• Qiagen NV
• RealSeq Biosciences Inc
• Roche Diagnostics International Ltd
• Seegene Inc
• Serimmune Inc
• Siemens Healthcare Diagnostics Inc
• T2 Biosystems Inc
• Taizhou ZECEN Biotech Co Ltd
• Techinvention Lifecare Pvt Ltd
• The Walter and Eliza Hall Institute of Medical Research
• Transfusion & Transplantation Technologies (Inactive)
• University of California
• University of Colorado
• University of Edinburgh
• University of Georgia
• University of Grenoble Alpes
• University of Oxford
• University of Tennessee
• Virginia Commonwealth University
• Washington University in St Louis
• Washington University School of Medicine

For more information about this report visit https://www.researchandmarkets.com/r/djd3pp

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900